Executive record

Andrew K. Balo

Director at Glucotrack, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:andrew-k-baloVersion: public-0As of: 2026-09-30

Not yet claimed7 published Claims3 sources
  • Director

Key Claims

Biography

Mr. Balo has served as director since June 2024 and was part of DexCom's original executive team in 2002, serving as EVP of Clinical, Global Access, and Medical Affairs until his retirement in March 2024. He previously held leadership positions at St. Jude Medical, Baxter, Pacesetter, and Endocardial Solutions.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. 2026 to end not publishedExecutive title: Director · Organization not publishedGCTK 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec proxy · Source published: Jul 17, 2026 · Retrieved: Sep 2, 2026

    Supports 1 claim
    • Professional Role: Director at Glucotrack, Inc. · Claim reviewed: May 16, 2026

  2. GCTK 10-K executive officers

    sec filing · Source published: Mar 30, 2026 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Glucotrack, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Director · Claim reviewed: May 16, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 16, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Glucotrack, Inc. · Claim reviewed: May 16, 2026